The conference served as a global platform for sharing advancements in the realm of human-computer interaction. Beatriz represented BEAMER and presented groundbreaking work accomplished within the project.
Her presentation revolved around the outcomes of Work Package 2, a pivotal phase involving the execution of a comprehensive stakeholder strategy. This expertly designed approach aimed to gather essential model requirements, playing a crucial role in shaping the direction of BEAMER’s research. The presentation delved into the intricacies of stakeholder engagement and highlighted results obtained through this collaborative approach.
A conference highlight was the acceptance of BEAMER’s study titled ‘Multi-stakeholder Approach for Designing an AI Model to Predict Treatment Adherence’.
This remarkable achievement underscores BEAMER’s commitment to developing innovative solutions that bridge the gap between technology and healthcare. In this study, semi-structured interviews were conducted with eleven stakeholders from four groups: patients, healthcare professionals, data scientists, and pharmacists. The needs and requirements received were categorised into four key aspects that were translated into requirements and needs: understanding the nature of the drivers, scope, and impact of the problem; identifying data sources; understanding relevant data points; and addressing potential ethical issues.
“We are thrilled to have our work recognized at such a prestigious international forum,” said Beatriz. “This acknowledgement is a testament to the hard work of the entire BEAMER team and the collaborative spirit of our stakeholders.”
Explore the study’s publication here, offering readers an in-depth exploration of the innovative approach and its potential impact on treatment adherence prediction.
Feel free to share your thoughts by contacting us
Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.
Disclaimer:
Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
The primary aim of the end user personas is to support the creation of materials to support the implementation of the BEAMER model framework and to help define requirements for the elements of the BEAMER model framework. Hence, healthcare professionals (HCPs) represent the primary envisaged end user group of the BEAMER model framework and the associated Adherence Intelligence Visualisation Platform (AIVP)
It is one learning from the joint design process that the job titles of healthcare professional team members do not necessarily predict the roles they would play within the change management process for implementing BEAMER and installing it as a standard model within healthcare. Additionally, the role and responsibilities of certain job titles, for example nurse, varies across different healthcare systems and would affect how they interact with the BEAMER model outputs and the access they would be permitted and so it would not be helpful to include these job titles: The four personas represent role-independent archetypes within the group of HCPs. They encompass a Managerial HCP Persona, an Implementer HCP Persona, a Support HCP Persona, and a Established HCP Persona.
These healthcare professional personas may be further tailored to specific healthcare settings depending on the needs of the individual pilot sites. Thus, adapted or spin-off versions of these original personas may be considered. The persona displays include a summarising statement, goals, challenges, experience, and needs to enhance the accessibility and usability of the model while minimising user burden.
Patient organisations are considered potential users of the model outputs. Consequently, personas were designed for these groups to assure that the implementation materials may also support their needs in the longer term, thus fostering sustainability of the project outputs.
The identified focus areas within this persona are goals, needs, skills and tools, along with potential challenges anticipated during the implementation process. The persona emphasises awareness-raising, capacity building, education, peer support provision, and the promotion of research and development in therapeutic care.
The patient organisation persona serves as a theoretical framework representing how patient organisations could benefit from and include the BEAMER model framework in their therapy and care related as well as their organisational work. This persona comprises the needs, goals, challenges and necessary tools, facilitating preparation and implementation of the model and optimising the user experience of patient organisations as end users of the BEAMER model framework. It can be used as a guide to identify potential obstacles and understand the prerequisites for a patient organisation to successfully adopt and integrate the BEAMER model framework.
“In implementing the BEAMER model, we want to be able to respond to the different needs of our patients to ensure their adherence, build a supportive community and improve outcomes.”